Frontlight ResearchEarly access
Trial site
Clinique Mémoire de Montréal
- 2running trials
- 1closed trial
The trials here
What the 3 trials at this site are about, from their registry records.
- Conditions
- Alzheimer disease3 trials
- Mild cognitive impairment2 trials
- Phase
- Phase 33 trials
- Status
- Active, not recruiting2 trials
- Completed1 trial
- Lead sponsor
- Hoffmann-La Roche2 trials
- Eli Lilly and Company1 trial
Running trials
Active, not recruiting
A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
Active, not recruiting
A Study of Remternetug (LY3372993) in Early Alzheimer's Disease (TRAILRUNNER-ALZ 3)
Closed trials
Site data: ClinicalTrials.govUpdated 17 Nov 2026